Modelled DT Structure
Method: homology modeling
Template PDB: 6S3Q_A
Identity: 54.583%
Minimized Score: -1182.984 kcal/mol
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0134 | ||||
| Gene Name | SLC1A6 | ||||
| Protein Name | Excitatory amino acid transporter 4 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: homology modeling Template PDB: 6S3Q_A Identity: 54.583% Minimized Score: -1182.984 kcal/mol Detail: Structure Info |
||||
| Synonyms | EAAT4; SLC1A6; Sodium-dependent glutamate/aspartate transporter; Solute carrier family 1 member 6 | ||||
| DT Family | Dicarboxylate/Amino Acid:Cation (Na(+) Or H(+)) Symporter (DAACS) Family ; | ||||
| Tissue Specificity | Brain. Expressed densely and selectively incell bodies of Purkinje cells. | ||||
| Function | This sodium-dependent, high-affinity amino acid transporter functions as a symporter and mediates the uptake of L-glutamate and also L-aspartate and D-aspartate. Mediates Cl(-) flux that is not coupled to amino acid transport; this avoids the accumulation of negative charges due to aspartate and Na(+) symport. Plays a redundant role in the rapid removal of released glutamate from the synaptic cleft, which is essential for terminating the postsynaptic action of glutamate. | ||||
| Endogenous Substrate(s) | Na+; Aspartate | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
(ε) Exogenous Modulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
(δ) Xenobiotics-regulated Structural Variability |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
L-glutamic acid
|
Approved | Drug Info | Schizophrenia | 6A20 | [1] |
| References | |||||
| 1 | The SLC1 high-affinity glutamate and neutral amino acid transporter family. Mol Aspects Med. 2013 Apr-Jun;34(2-3):108-20. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.